{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-24-001750","form_type":"8-K","ticker":"LNAI","cik":"0001527728","company_name":"Lunai Bioworks Inc.","filed_at":"2024-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.698146+00:00","generated_at":"2026-05-30T02:47:28.979996+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Renovaro amends consulting agreement with Interim CFO Simon Tarsh; $25k/month plus options","bullets":["Simon Tarsh continues as Interim CFO under amended agreement; monthly fee $25,000.","Tarsh received $29,063 bonus on Oct 31 and will receive another $29,063 on Nov 30.","Granted 58,500 stock options under 2023 Equity Incentive Plan; vest if new CFO hired before termination.","Agreement term is 3 months, renewable monthly; either party may terminate on 30 days notice.","Tarsh eligible for target bonus up to 30% of total consideration if milestones achieved (timely SEC filings and new CFO)."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-24-001750","json":"https://secwatch.observer/filing/0001731122-24-001750.json","markdown":"https://secwatch.observer/filing/0001731122-24-001750.md","text":"https://secwatch.observer/filing/0001731122-24-001750.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001750/0001731122-24-001750-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001750/e6107_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:47:28.979996+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}